Top Story
Arbutus Biopharma Corporation (NASDAQ: ABUS): Would You Buy Today?
In the last trading session, 7.06 million shares of the Arbutus Biopharma Corporation (NASDAQ:ABUS) were traded, and its beta was 2.60. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.